Below is a representative list of participating investors for the 2020 CEO & Investor Conference:

3E Bioventures
A C Binder
Accelmed Partners
Aceras Partners
Acorn Bioventures
Acuitas Capital
Aditum Bio
Adjuvant Capital
Affinity Asset Advisors
Aisling Capital LLC
Aleph Capital 
Alignment Ventures
Alliance for Aging Research
Alliance for Cancer Gene Therapy
Alnitak Capital
Andreessen Horowitz
Anson Funds
Aracle Capital LLC
ARCH Venture Partners
Arix Bioscience
Armistice Capital
Arsenal Capital Partners
Ascendiant Capital Markets
Ashford Capital Management
Aspire Capital
Asset Management Ventures
Astellas Pharma US
Astellas Venture Management
Astute Capital
ATEM Capital
Atheneos Ventures
Ayrton Capital
Bank of America Merrill Lynch
Bathala Capital
Beacon Capital
Berenberg Capital Markets
Bifrost Capital
Bigger Capital Fund
BIMA Capital
Biocoast Capital
BioInnovation Capital
Biondo Investment Advisors
Bios Partners
BioSense Global
Biotech Alliances International
Biotech Investment Group
Black Diamond Advisors
Blue Rock Capital Advisors
Bohe Angel Fund
Bojian Capital
Brace Pharma Capital
Bridge Bank
Brock Capital Group
Brookline Capital Markets
Bryan, Garnier & Co.
Canaccord Genuity
Capital Family Office
Caxton Alternative Management
Chaperone Investment
Chardan Capital Markets
Charlestown Capital
Chronon Capital
Church Pension Fund
CJ Seligman & Co.
Cowen Healthcare Investments
Cowin Venture
Crescent Capital Ventures
Crosswave Management
CSC Leasing
CTI Capital Gestion Inc.
CTTQ Pharmaceutical Group
CyberMed Holdings
Dabar Investment Associates
DB Capital
Deca Ventures
Deerfield Management Company
DEFTA Partners
Delaware Innovation Space
Deltec Bank
Delwar Capital Management
Deutsche Bank
District 2 Capital
Douglas C. Lane & Associates
DTB Capital Management
Dynamk Capital
E Squared Asset Management
E Squared Capital
Easton Capital
Edgewood Management
EG Capital Advisors
Ensconce Capital
Esousa Holdings
ETP Global Fund
EVOLUTION Life Science Partners
Executive Forum Angels
Exome Asset Management
Fannin Innovation Studio
FC Capital
First Island Capital
First Seafront Fund Management
FMG Ventures
Fortress Biotech
Fountain Healthcare Partners
Foxhill Asset Management
Franklin Global Partners
Frigate Capital Management
Fujifilm Capital Management
Gagnon Securities
Global Founders Capital
Global Neurohealth Ventures
Golden Eagle Capital Advisors
Goldwater Asset Management
Good Health Capital
Grey Sky Venture Partners
H.C. Wainwright & Co.
H.I.G. BioHealth Partners/span>
H.I.G. Capital Management
Hannol Ventures
Harbin Pharmaceutical Group
Harvard Investors Group
Health Innovative Technology Corporation
HealthCare Royalty Partners
HEDA Ventures
Hercules Capital
Hibiscus Bioventures
HighCape Capital
Highland Capital Management
Horizon Technology Finance
Hudson East Capital
Hudson Square Capital
Hyperplane VC
Inbio Ventures
Ingenio Therapeutics / Mayewell Capital
InMed Pharmaceuticals
Innovent Biologics
inThought Research
Inukshuk Capital
ISAR Capital Management
J.H. Darbie & Co.
J.W. Childs Associates
Janney Montgomery Scott
Jiangsu Hengrui Medicine Co.
Jina Ventures
JM Cohen & Co.
Johnston Associates
J.P. Morgan

K2 HealthVentures
Kalka Fund
Krensavage Asset Management
Ladenburg Thalman
Laidlaw Venture Partners
Life Sciences Greenhouse of Central PA
LifeNet Health
LifeScience EquityPartners
LifeTech Capital
Lincoln Park Capital
Lions Bay Capital
Lumira Ventures
Lyfe Capital
Madryn Asset Management
Magid Family Office
Maxim Group
MAZ Capital Advisors
MedPro Investors
Merlin Nexus
Mid Atlantic Bio Angels
MIT Alumni Angels of Northern California
Mitsui & Co. Global Investment
Mizuho Corporate Bank
Mizuho Securities
Morgan Capital
Mountain Brook Capital
MV Corp Services
MVP Capital Partners
National Holdings Corporation
NauVista Capital Management
NCL Technology Ventures
Needham & Co.
Network 1 Financial Securities
Neurotrope, Inc.
New Jersey Investment Division
New York Angels
Newburgh Bay Capital
NGN Capital
Noble Equity Fund
Northlea Partners
Novatio Ventures
Novo Ventures
NYC Medtech/Perselson
Oasis Capital
Oberland Capital
Omega Funds
Oppenheimer & Co.
Opto Capital Group
Oracle Partners
Orange Grove Bio
OrbiMed Advisors
Orchard View Capital Advisors
Otsuka Pharmaceutical Co.
Oxford Finance
Pacific Western Bank
Pappas Capital
Park Ave. Capital Management International
Parkman Healthcare Partners
Parkville Advisors
Peak One Investments
Perseverance Capital Advisors
Petrichor Healthcare Capital Management
Pharmakon Advisors
Piper Sandler
Premier Partners
Prevail Partners
Princeton Biopharma
Prism Biomedical Research
Promethean Capital Group
Quan Capital
Raymond James
Remsen Investors
Revach Fund
RHK Capital
Robert W. Baird & Co.
Rosetta Capital
Roth Capital Partners
RW Baird
Sagard Holdings
Sandhill Angels
Santen Pharmaceutical Co.
Sarissa Capital Management
Satter Medical Technology Partnership
SDIC Fund Management
Second Line Capital Management
Sector Asset Management
Serrado Capital
Shanghai Henlius Biotech
Shaw Strategic Capital
Signature Bank
Simcere Pharmaceutical Group
Simrx Advisors
Sio Capital Management
Sky Ventures Group
Smilegate Investment
Sofinnova Ventures
Solar Capital Partners
Sound Affects
Special Situations Funds
SPRIM Ventures
SR One
Starlink Capital
Stonehenge Capital
Strathspey Crown
Sun Pharmaceuticals
SunTrust Robinson Humphrey
Surveyor Capital
Taiho Ventures
Tang Capital Management
Tectonic Capital
Terra Stone Capital
The Abraham Group
The Anson Group
The Astrologers Fund
The Benchmark Company
The Center for Performance Investing
The Engine
The Leukemia & Lymphoma  Society
The Lind Partners
Think Equity
Tokyo Stock Exchange
Tosoh USA
Treehill Principal Strategies
Tryphon Capital Advisors
University of Notre Dame
Unterberg Capital
Upstream Partners
V2m Life Sciences Fund
Varana Resource Funds
Vector Point Ventures
Vector Resource Funds
Vista Capital Advisors
Vista Point Capital
Voya Financial
W Global Capital Limited
Wallachbeth Capital
WBB Securities
Western International
Westlake Ventures
Wexford Capital
Wick Capital Partners
Wolpert Associates
Xeraya Capital Life Venture
Xerion Investments
YA Global
Yale University, Office of Cooperative Research
YILGA Management Services
Young America Capital
Zacks Small Cap Research
Zeniths Capital
ZJ Future 


*As of 2/5/2020